Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing ...

A grassroots organization that formed with the goal of recalibrating cancer care around patient needs issued guidance ...

Trial Platform (PTP), led by Drs. Adam Boxer (University of California, San Francisco [UCSF]), Irene Litvan (University of California, San Diego), Julio Rojas (UCSF) and ...

NanoViricides, Inc. (NYSE American: NNVC) provided an update on its Measles drug development program, highlighting the potential of its broad-spectru ...

Cordyceps Sunshine Biotech Holdings Co., Ltd.【C.S Group】 announced a major milestone in veterinary drug development at the ...

Despite the failures, ALX Oncology remains hopeful about evorpacept and is focusing on combination trials with other ...

Sanofi will halt the development of its oral tumour necrosis factor (TNF) inhibitor balinatunfib as a monotherapy after it ...

South Korea is emerging as a key player in global pharmaceuticals, driven by an advanced healthcare ecosystem, strategic government initiatives, and robust research infrastructure. The nation's focus ...

Sanofi’s development of an oral spin on Humira’s mechanism has hit a setback. | Sanofi’s development of an oral spin on ...